FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
BEFREE |
To address this question, we generated cellular knock-out models of FA core complex components and FANCD2 and found that FANCD2-null mutants display higher levels of spontaneous chromosomal damage and hypersensitivity to replication-blocking lesions than Fanconi anemia complementation group L (FANCL)-null mutants, suggesting that FANCD2 provides a basal level of DNA protection countering endogenous lesions in the absence of monoubiquitination.
|
29021208 |
2017 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
GeneticVariation
|
disease |
CLINVAR |
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
|
27153395 |
2016 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
GeneticVariation
|
disease |
CLINVAR |
Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.
|
25239263 |
2015 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
GeneticVariation
|
disease |
CLINVAR |
FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.
|
25659033 |
2015 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss-of-Function FANCL Mutations Associate with Severe Fanconi Anemia Overlapping the VACTERL Association.
|
25754594 |
2015 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss-of-Function FANCL Mutations Associate with Severe Fanconi Anemia Overlapping the VACTERL Association.
|
25754594 |
2015 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Loss-of-Function FANCL Mutations Associate with Severe Fanconi Anemia Overlapping the VACTERL Association.
|
25754594 |
2015 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
GeneticVariation
|
disease |
CLINVAR |
Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
|
23613520 |
2013 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
How the fanconi anemia pathway guards the genome.
|
19686080 |
2009 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
|
19405097 |
2009 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
GeneticVariation
|
disease |
CLINVAR |
Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
|
19405097 |
2009 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5.
|
16474160 |
2006 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.
|
12724401 |
2003 |
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
FANCONI ANEMIA, COMPLEMENTATION GROUP L
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|